JCAM

JCAM is a forex and CFD broker registered in the United Kingdom, with its official domain at jcamtrade.com. According to our records, the company was founded on 4 January 2018 and is headquartered in Hong Kong, though its registered address is at Eagle House, 108-110 Jermyn Street, London. The broker claims to be regulated by the Financial Conduct Authority (FCA) under an Institutional Derivative Trading License (STP), but its FCA status is marked as 'unsubscribed' in the regulator's register, meaning it is no longer an authorised firm.

While JCAM indicates FCA regulation, the unsubscribed status raises significant concerns about the current validity of its licence. Traders should verify any regulatory claims directly with the FCA register. The firm provides customer service via phone (40085587) and email (CS@jcamforex.com), and supports trading through the popular MetaTrader 4 and MetaTrader 5 platforms.

Based on the company description, JCAM offers trading via MT4 and MT5 systems, suggesting access to forex, CFDs, and possibly other asset classes. However, specific details about available instruments, spreads, leverage, or account types are not publicly available from independent sources at this time. The absence of verified trading conditions means traders must exercise caution.

JCAM lists its registered address in London, yet its operational base is stated as Hong Kong, where it claims to have been established since 1997. This discrepancy in founding dates (1997 vs. 2018) and the mix of jurisdictions may indicate a complex corporate structure. The broker's telephone and email contact details suggest a focus on client support, but no independent verification of these channels exists.

Given the regulatory uncertainty and limited independent information, JCAM may not be suitable for risk-averse traders or those requiring strong regulatory protection. The broker's target audience appears to be retail traders, but the lack of transparent regulatory status makes it a high-risk choice. Beginner traders are advised to consider fully regulated alternatives.